Healthcare -
Biotechnology - NASDAQ - US
$ 2.58
6.17 %
$ 74.5 M
Market Cap
-0.86
P/E
AVTE - CHANGE IN WORKING CAPITAL
Change in Working Capital AVTE - Aerovate Therapeutics, Inc.
9.8 M
LAST VALUE
87.22%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR